김정희 교수
학력
2005서강대학교 졸업 2009경희대학교 의학전문대학원 졸업 2024성균관대학교 의과대학 의학박사 |
경력
2009 ~ 2014성균관의대 삼성서울병원 수련의 및 내과 전공의 2014 ~ 2017성균관의대 삼성서울병원 소화기내과 임상강사 2017 ~ 2019한강성심병원 소화기내과 임상조교수 2019 ~ 2024동탄성심병원 소화기내과 조교수 2024 ~ 동탄성심병원 소화기내과 부교수 |
학회활동
대한간학회 정회원 대한간암학회 정회원 복부 초음파 세부전문의 및 지도전문의 소화기내시경 세부전문의 |
논문/저서
|
국제학회지 발표논문 1.Kim Jung Hee, Rethinking ACLF Prognosis: Can Machine Learning Outperform Conventional Scores? Editorial on: Predictive Machine Learning model in ICU Patients with Acute-on-Chronic Liver Failure and Two or More Organ Failures. Clin Mol Hepatol. 2025 Sep 23. 2.Kim Jung Hee, Yoon JH, Kim SE et al. Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study, Medicina (Kaunas),2025 Sep 4;61(9):1601. 3.Sohn W, Lee YS, Kim SS, Kim Jung Hee, Jin YJ, Kim GA, et al. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025. Clin Mol Hepatol. 2025;31(Suppl):S1-S31 4.Kim Jung Hee, Kim SE, Song DS et al. Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study. Ann Med. 2025 Dec;57(1):2428431 5.Kim, Jung Hee, Sung-Eun Kim et al., The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study, Diagnostics, 2024; 14(1):14. 6.Jihye Lim, Jung Hee Kim et al. Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohort, Journal of Gastroenterology and Hepatology, 08 May 2024 7.Kim Jung Hee, Chang JI et al., Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study. Gut Liver. 2023 Jul 15;17(4):620-628.3 8.Kim Jung Hee, Ji-Won Park, et al. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics, Biomedicines. 2022 May 31;10(6):1288. 9.Kim Jung Hee, Kim SE, et al. Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration. J Clin Med. 2022 Apr 7;11(9):246 10.Kim Jung Hee, Se Woo Park et al. Bedside risk-scoring model for predicting 6-week mortality in cirrhotic patients undergoing endoscopic band ligation for acute variceal bleeding, Journal of and Hepatology 36 (2021) 1935–1943 11.Kim Jung Hee, Min Chul Kim et al. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease. Plos One, October23, 2020 12.Kim Jung Hee, Won Sohn, and Ju-Yeon Cho. Effect of acute kidney injury on long-term Outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites-acute kidney injury criteria, Journal of Gastroenterology and Hepatology 35 (2020) 870– 876 13.Kim Jung Hee, Sinn DH. Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change? Clin Mol Hepatol. 2020 Jul;26(3):315-317. 14.Kim Jung Hee, Sinn DH et al. Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization. Dig Dis Sci. 2018 Apr;63(4):1062-1071. 15.Kim Jung Hee, Dong Hyun Sinn, Geum-Youn Gwak et al. Low-level virema and the increased risk of hepatocellular carcinoma in patient receiving entecavir treatment, Hepatology,2017 Aug;66(2):335-343 16.Kim Jung Hee, Kyung Sook Lim,Yang Won Min et al.Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis, Journal of Gastroenterology and Hepatology,2017 May;32(5):1064-1070 17.Kim Jung Hee, Dong Hyun Sinn, Geum-Youn Gwak et al., Insulin resistance assessment is useful in risk stratification of hepatocellular carcinoma in chronic hepatitis B patients, Journal of Gastroenterology and Hepatology, 2017 May;32(5):1100-1106 18.Kim Jung Hee, Sinn DH, Shin SW, Cho SK, et al., The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE. Clin Mol Hepatol. 2017 Mar;23(1):42-50. 19.Kim Jung Hee, Min, Yang Won, Gwak, Geum-Youn,Paik et al. The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma, Medicine (Baltimore). 2016 Dec;95(51):e5666 20.Kim Jung Hee, Dong Hyun Sinn, Kyunga Kim,et al. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy. Medicine (Baltimore). 2016 Aug;95(35):e4735 21.Kim Jung Hee, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang et al. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma. Dig Dis Sci (2016) 61:3354–3362 22.Kim Jung Hee, Dong Hyun Sinn, Kyunga Kim et al., Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma. Gut and Liver, Vol. 10, No. 6, November 2016, pp. 939-947 23.Kim Jung Hee, Jun Haeng Lee. Effect of One Hour Endoscopy Learning Session on Interobserver Variation of Endoscopic Classification of Early Gastric Cancer, The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2015;15(3):207-209 |